Two events and a book signing are being held to help prescribers and patients better understand Low Dose Naltrexone (LDN) on Thursday, September 5th, 2024 at 348 E Irving Park Road, Roselle, Illinois 60172.
Mark Drugs Pharmacy is inviting prescribers and patients interested in learning about the importance of LDN use in addressing complex health issues and providing hope to the chronically ill. The pharmacy specializes in custom compounding medications to ensure that patients receive proper prescriptions tailored to their unique needs and conditions. They aim to improve patient health and enhance their overall quality of life by collaborating with various practitioners and integrating their knowledge and treatment approaches to develop comprehensive health plans.
The morning session will feature speakers Linda Elsegood, founder of LDN Research Trust and author of New Horizons, as well as pharmacists Dr. Teresa Selvaggio and Jeff Lundgren from Mark Drugs. The evening session will include Linda and Teresa, joined by Roxana Calafos, LDN prescriber from Motivated Medicine.
These events, along with the book signing, will provide valuable insight into LDN and raise awareness of LDN and the LDN Research Trust.
LDN is an opioid receptor antagonist that helps reduce pain and fight inflammation. It is used to treat conditions such as cancer, autoimmune diseases, chronic pain, and mental health issues.
EVENT TIMINGS:
Thursday, September 5th, 2024
Morning session – 11:30 AM – 1:00 PM with light refreshments
Evening session – 6:30 PM to 9:00 PM with buffet dinner
The event coincides with the recent publication of “New Horizons: Celebrating 20 Years of the LDN Research Trust” and will include a book signing by its author, Linda Elsegood. Linda said, “These events help demonstrate the importance of prescribers, pharmacists and patients working together to achieve the best possible outcomes with LDN.”
For more information and to RSVP, please email: pete@quitegreat.co.uk
skype – quitegr8
Leave a Comment